Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

219 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials.
Abargouei AS, Janghorbani M, Salehi-Marzijarani M, Esmaillzadeh A. Abargouei AS, et al. Among authors: janghorbani m. Int J Obes (Lond). 2012 Dec;36(12):1485-93. doi: 10.1038/ijo.2011.269. Epub 2012 Jan 17. Int J Obes (Lond). 2012. PMID: 22249225 Review.
Prevalence of overweight and thinness in high-school girls in Kerman, Iran.
Janghorbani M, Parvin F. Janghorbani M, et al. Int J Obes Relat Metab Disord. 1998 Jul;22(7):629-33. doi: 10.1038/sj.ijo.0800638. Int J Obes Relat Metab Disord. 1998. PMID: 9705021
Does bromocriptine improve glycemic control of obese type-2 diabetics?
Aminorroaya A, Janghorbani M, Ramezani M, Haghighi S, Amini M. Aminorroaya A, et al. Among authors: janghorbani m. Horm Res. 2004;62(2):55-9. doi: 10.1159/000078932. Epub 2004 Jun 11. Horm Res. 2004. PMID: 15205563 Clinical Trial.
Coronary heart disease in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors.
Janghorbani M, Amini M, Tavassoli A. Janghorbani M, et al. Acta Cardiol. 2006 Feb;61(1):13-20. doi: 10.2143/AC.61.1.2005135. Acta Cardiol. 2006. PMID: 16485728
A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke.
Ashtary F, Janghorbani M, Chitsaz A, Reisi M, Bahrami A. Ashtary F, et al. Among authors: janghorbani m. Neurology. 2006 Mar 28;66(6):914-6. doi: 10.1212/01.wnl.0000203119.91762.0c. Neurology. 2006. PMID: 16567711 Clinical Trial.
Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V. Shaygannejad V, et al. Among authors: janghorbani m. Headache. 2006 Apr;46(4):642-8. doi: 10.1111/j.1526-4610.2006.00413.x. Headache. 2006. PMID: 16643559 Clinical Trial.
Prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F. Etemadifar M, et al. Among authors: janghorbani m. Neuroepidemiology. 2006;27(1):39-44. doi: 10.1159/000094235. Epub 2006 Jun 27. Neuroepidemiology. 2006. PMID: 16804333
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture.
Janghorbani M, Van Dam RM, Willett WC, Hu FB. Janghorbani M, et al. Am J Epidemiol. 2007 Sep 1;166(5):495-505. doi: 10.1093/aje/kwm106. Epub 2007 Jun 16. Am J Epidemiol. 2007. PMID: 17575306 Review.
First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults.
Janghorbani M, Amini M, Willett WC, Mehdi Gouya M, Delavari A, Alikhani S, Mahdavi A. Janghorbani M, et al. Obesity (Silver Spring). 2007 Nov;15(11):2797-808. doi: 10.1038/oby.2007.332. Obesity (Silver Spring). 2007. PMID: 18070771
The criteria for underweight, normal-weight, overweight, and Class I, II, and III obesity were BMI <18.5, 18.5 to 24.9, 25 to 29.9, 30 to 34.9, 35 to 39.9, and >or=40 (kg/m(2)), respectively. ...RESULTS: The age-adjusted means for BMI and WC were 24.6 kg/m(2) …
The criteria for underweight, normal-weight, overweight, and Class I, II, and III obesity were BMI <18.5, 18.5 to 24.9, 25 to 29.9, 30 to …
Metabolic syndrome in type 2 diabetes mellitus in isfahan, iran: prevalence and risk factors.
Janghorbani M, Amini M. Janghorbani M, et al. Metab Syndr Relat Disord. 2007 Sep;5(3):243-54. doi: 10.1089/met.2005.0010. Metab Syndr Relat Disord. 2007. PMID: 18370778
219 results
Jump to page
Feedback